DCF Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,250
| Closed | -$305K | – | 74 |
|
|
2023
Q3 | $305K | Buy |
+5,250
| New | +$305K | 0.17% | 61 |
|
|
2022
Q1 | – | Sell |
-32,500
| Closed | -$2.03M | – | 62 |
|
|
2021
Q4 | $2.03M | Hold |
32,500
| – | – | 0.82% | 32 |
|
|
2021
Q3 | $1.92M | Sell |
32,500
-8,000
| -20% | -$473K | 0.85% | 29 |
|
|
2021
Q2 | $2.71M | Buy |
40,500
+500
| +1% | +$33.4K | 0.96% | 24 |
|
|
2021
Q1 | $2.53M | Hold |
40,000
| – | – | 1.1% | 24 |
|
|
2020
Q4 | $2.48M | Sell |
40,000
-1,500
| -4% | -$93K | 1.02% | 26 |
|
|
2020
Q3 | $2.5M | Buy |
41,500
+1,500
| +4% | +$90.4K | 1.28% | 24 |
|
|
2020
Q2 | $2.35M | Sell |
40,000
-19,000
| -32% | -$1.12M | 1.32% | 23 |
|
|
2020
Q1 | $3.29M | Sell |
59,000
-500
| -0.8% | -$27.9K | 2.15% | 12 |
|
|
2019
Q4 | $3.82M | Buy |
+59,500
| New | +$3.82M | 2.42% | 13 |
|